NATCO Pharma launches generic Bosentan tablets for oral suspension in the United States EP News Bureau Aug 20, 2025 NATCO partners with Lupin for Bosentan tablets, gains 180-day exclusivity for pulmonary arterial hypertension treatment in…
Alembic Pharmaceuticals receives USFDA approval for Macitentan Tablets, 10 mg EP News Bureau Aug 19, 2025 Alembic Pharmaceuticals secures final approval for its ANDA Macitentan Tablets, a therapeutic equivalent of Actelion’s Opsumit,…
